Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Campaigns were Conducted against the Ministry because of its Minister's Stances; some Dossiers were Excluded from the Cabinet's Agenda

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani stressed that false information has been circulated concerning the financial ceilings and the performance of the Lebanese Forces ministers was criticized, while these latter ministers have proved to be an example that should be followed in the government.  

Hasbani was quoted as saying by the state-run Tele Liban the financial prosecutor heard Tuesday two counselors who were found innocent. “We respect any judicial decision taken and the allegations and what was said about us were found to be wrong,” Hasbani added.

The financial ceilings

Hasbani explained the issue of the financial ceilings saying that in the previous years no mechanism was adopted for these ceilings which were set without clear standards. “We have adopted a mechanism based on the size of the hospital, the real number of beds, the services provided and the cost of bed. We found out that the declared number of beds in the syndicate was incorrect. The head of the association was informed and we adopted the existing number of beds in each hospital.”

“The mechanism for the financial ceilings that we have submitted to the cabinet since 2017 was not included in the agenda. Therefore, we referred to the powers stipulated in the law that give the minister the right to amend the financial ceilings as needed,” the Minister of Public Health added.

No shortage in drugs

As for drug shortages, Hasbani noted that there was no lack of free drugs in Quarantine and all what has been circulated was not true. There are many drugs of which prices were cut off according to a specific mechanism.

“The drugs available in the Lebanese markets are from all the countries and abide by all mechanisms and conditions. 25 thousand patients benefit from the drugs provided by the Ministry of Public Health,” Hasbani added.

The Ministry of Public Health conducts permanent awareness campaigns to prevent diseases. An awareness campaign on obesity will be launched soon, knowing that these campaigns receive technical and financial support from the World Health Organization and the World Bank respectively.
 
Food Safety


Hasbani tackled food safety saying that the Ministry of Public Health conducted 29 thousand inspections and issued 10 thousand warnings. “We have never heard about them in the media because they tarnish the reputation of the Lebanese food sector. We have also launched the Application “Ballegh Lel Soha” that enables the citizens to report to the ministry on any violation,” Hasbani noted
    1
    ...
ATC Name B/G Ingredients Dosage Form Price
R01AD09 TABUNEX G Mometasone furoate - 0.05% 0.05% Spray 419,279 L.L
C09CA03 TABUVAN G Valsartan - 80mg 80mg Tablet, film coated 387,027 L.L
C09CA03 TABUVAN G Valsartan - 160mg 160mg Tablet, film coated 544,256 L.L
C02CA06 TACHYBEN G Urapidil - 25mg/5ml 25mg/5ml Injectable solution 1,439,255 L.L
L04AD02 TACROGRAF 0.5 G Tacrolimus - 0.5mg 0.5mg Capsule 7,004,024 L.L
L04AD02 TACROGRAF 1 G Tacrolimus - 1mg 1mg Capsule 12,679,940 L.L
L04AD02 TACROGRAF 5 G Tacrolimus - 5mg 5mg Capsule 67,507,154 L.L
D11AH01 TACRUS G Tacrolimus monohydrate - 0.1% 0.1% Ointment 1,857,190 L.L
G04BE08 TADALAFIL BIOGARAN G Tadalafil - 5mg 5mg Tablet, coated 3,369,013 L.L
G04BE08 TADALAFIL BIOGARAN G Tadalafil - 10mg 10mg Tablet, coated 1,397,596 L.L
G04BE08 TADALAGEN G Tadalafil - 20mg 20mg Tablet, film coated 1,032,839 L.L
G04BE08 TADALAGEN G Tadalafil - 5mg 5mg Tablet, film coated 1,766,193 L.L
G04BE08 TADAPRESS G Tadalafil - 20mg 20mg Tablet, film coated 13,621,308 L.L
G04BE08 TADILAS G Tadalafil - 20mg 20mg Tablet, film coated 607,417 L.L
G04BE08 TADILAS G Tadalafil - 5mg 5mg Tablet, film coated 1,583,046 L.L
P02DA01 TAENIASAN G Niclosamide - 500mg 500mg Tablet 94,709 L.L
S01EE05 TAFLUPRO G Tafluprost - 0.0015% 0.0015% Solution 1,912,288 L.L
J01AA12 TAGIX G Tigecycline - 50mg 50mg Injectable lyophilised powder for solution 2,436,386 L.L
L01EB04 TAGRISSO B Osimertinib - 80mg 80mg Tablet, film coated L.L
L01EB04 TAGRISSO B Osimertinib - 80mg 80mg Tablet, film coated 603,192,941 L.L
B06AC05 TAKHZYRO BioTech Lanadelumab - 300mg/2ml 300mg Injectable solution L.L
B06AC05 TAKHZYRO BioTech Lanadelumab - 300mg/2ml 300mg Injectable solution 1,202,366,121 L.L
B06AC05 TAKHZYRO BioTech Lanadelumab - 300mg/2ml Injectable solution 1,204,227,927 L.L
L04AC13 TALTZ BioTech Ixekizumab - 80mg/ml 80mg/ml Injectable solution 85,080,792 L.L
G04CA02 TALUSIN G Tamsulosin HCl - 0.4mg 0.4mg Capsule, modified release 683,440 L.L
L01FX29 TALVEY B Talquetamab - 2mg/ml 3mg/1.5ml Injectable solution 45,594,403 L.L
L01FX29 TALVEY B Talquetamab - 40mg/ml 40mg/ml Injectable solution 555,916,745 L.L
G04BE08 TALYS G Tadalafil - 20mg 20mg Tablet, film coated 1,032,839 L.L
G04BE08 TALYS G Tadalafil - 20mg 20mg Tablet, film coated 275,680 L.L
G04BE08 TALYS G Tadalafil - 5mg 5mg Tablet, film coated 1,574,216 L.L
    1
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026